Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼Ò¾Æ ³­Ä¡¼º ºÎºÐ °£Áú ȯÀÚÀÇ ¼ö¼úÀû Ä¡·á Epilepsy Surgery in Children with Intractable Partial Epilepsies

´ëÇѼҾƽŰæÇÐȸÁö 2001³â 9±Ç 2È£ p.344 ~ 350
¼Ò¼Ó »ó¼¼Á¤º¸
ȲÈñ/Hee Hwang ±Ç¿µ¼¼/ÀÌÁ¾È­/À̶õ/äÁ¾Èñ/±è±âÁß/Ȳ¿ë½Â/Á¶º´±Ô/Young Se Kwon/Jong Hwa Lee/Ran Lee/Jong Hee Chae/Ki Joong Kim/Yong Seung Hwang/Byung Kyu Cho

Abstract

¸ñÀû: ³­Ä¡¼º ºÎºÐ°£Áú ȯÀÚ¿¡¼­ ¼ö¼úÀü Áø´Ü ¹æ¹ýµéÀÇ °¡Ä¡ ¹× Á¤È®µµ, ¼ö¼úÀû Ä¡·áÀÇ °á°ú ¹× È¿À²¼º, º´¸®Á¶Á÷ÇÐÀû Ư¼º µîÀ» Á¤¸®ÇÏ¿© ÀûÀýÇÑ ¼ö¼úÀû Ä¡·áÀÇ ±âÁØÀ» Á¦½ÃÇÏ°íÀÚ ÇÏ¿´´Ù.

¹æ¹ý: °£Áú ¼ö¼úÀ» ½ÃÇàÇÑ ¼Ò¾Æ ³­Ä¡¼º ºÎºÐ°£Áú ȯÀÚ 47¸íÀ» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ³²ÀÚ 26¸í ¿©ÀÚ 21¸íÀ̾ú°í, Æò±Õ ¹ßº´ ¿¬·É 6³â 2°³¿ù, ¼ö¼ú½Ã Æò±Õ ¿¬·É 9³â 1°³¿ùÀ̾úÀ¸¸ç, ¼ö¼ú ÈÄ Æò±Õ ÃßÀû °üÂû ±â°£Àº 29°³¿ùÀ̾ú´Ù. ¼ö¼úÀü Æò°¡·Î ¹ßÀÛ°£±â³úÆÄ,
¹ßÀÛ±â
³úÆÄ, ³ú MRI, FDG-PET°ú ¹ßÀÛ°£±â ¹× ¹ßÀÛ±â SPECT µîÀ» ½ÃÇàÇÏ¿´´Ù. °£ÁúÀº ÃøµÎ¿± °£Áú, ÀüµÎ¿± °£Áú, µÎÁ¤¿± °£Áú, Èĵο± °£Áú·Î ±¸ºÐÇÏ¿´´Ù. ¼ö¼ú ÈÄ °á°ú´Â Engel ºÐ·ù¿¡ µû¶ú´Ù.

°á°ú:

1) 47¸í Áß 28¸íÀÌ ÃøµÎ¿±, 8¸íÀÌ ÀüµÎ¿±, 8¸íÀÌ Èĵο± °£ÁúÀ̾ù°í 3¸íÀÌ µÎÁ¤¿± °£ÁúÀ̾ú´Ù. 28¸íÀº ÃøµÎ¿± ÀýÁ¦¼úÀ» 19¸íÀº ÃøµÎ¿±¿Ü ÀýÁ¦¼úÀ» ½ÃÇà ¹Þ¾Ò´Ù.

2) º´¸®°Ë»ç»ó ÃøµÎ¿± °£Áú 28¸í Áß ÇÇÁú ÀÌÇü¼ºÁõ 5·Ê, Çظ¶ °æÈ­Áõ 8·Ê, °æÈ­Áõ°ú ÇÇÁú ÀÌÇü¼ºÁõÀÇ °øÁ¸ 8·Ê, ÇÇÁú ÀÌÇü¼ºÁõ°ú Á¾¾çÀÇ °øÁ¸ 4·Ê, ÇÇÁú ÀÌÇü¼ºÁõ, Á¾¾ç, Çظ¶ °æÈ­ÁõÀÇ °øÁ¸ 1·Ê, Á¾¾ç 2·Ê¿´´Ù. ÃøµÎ¿±¿Ü °£ÁúȯÀÚ 19¸í Áß ÇÇÁú ÀÌÇü¼ºÁõÀÌ 16·Ê,
Á¾¾ç
2·Ê, À̼Ҽº ½Å°æ¿øÁõ 1·Ê¿´´Ù.

3) MRI, ¹ßÀÛ°£±â ¹× ¹ßÀÛ±â SPECT, FDG-PETÀÇ °Ë»ç ¾ç¼º·üÀº °¢°¢ 78.7%, 35.3%, 77.3%, 95.7%·Î FDG-PETÀÌ °¡Àå ³ô¾Ò´Ù(P value<0.05).

4) ¿µ»ó °Ë»ç»ó ¾ç¼º°ú ¹ßÀ۱⠳úÆÄ¿ÍÀÇ ±¹¼ÒÈ­ ÀÏÄ¡µµ´Â MRI 86.5%, ¹ßÀÛ°£±â SPECT 83.3%, ¹ßÀÛ±â SPECT 70.6%, FDG-PET 72.7%·Î MRIÀÇ ÀÏÄ¡µµ°¡ °¡Àå ³ô¾Ò´Ù(P value<0.05).

5) ¼ö¼ú ÈÄ °á°ú´Â Engel ºÐ·ù class ¥° 34·Ê(72.3%), class ¥± 4·Ê(8.5%), class ¥² 3·Ê(6.4%), class ¥³ 6·Ê(12.8%)¿´´Ù.

6) Favorable outcomeÀº ÃøµÎ¿± ÀýÁ¦¼ú 82.1%, ÃøµÎ¿±¿Ü ÀýÁ¦¼ú 73.7%¿¡¼­ ÀÖ¾ú´Ù(P value>0.05).

7) ¼ö¼ú ÈÄ ºÎÀÛ¿ëÀ¸·Î ½Ã¾ß°á¼Õ 4·Ê, µÎ°³°­³» ³ó¾ç 1·Ê, ÀϽÃÀû ¹Ý½Å¸¶ºñ 3·Ê µîÀ̾ú´Ù.

°á·Ð: ¼Ò¾Æ ³­Ä¡¼º ºÎºÐ °£ÁúÀÇ ¼ö¼úÀû Ä¡·á´Â ¹ßÀÛÀÇ Á¶Àý¿¡ ÀÖ¾î ¾çÈ£ÇÑ °á°ú¸¦ º¸¿´´Ù. ÇâÈÄ ´õ ¼¼¹ÐÇÏ°í °³º°ÀûÀÎ ¼ö¼úÀü Æò°¡, ¼ö¼úÈÄ °ü¸®, Àå±âÀû ÀÎÁö±â´É ¹ß´Þ µî¿¡ °üÇÑ ¿¬±¸°¡ ÇÊ¿äÇÒ °ÍÀÌ´Ù.

Purpose: Few studies have been performed on the value and efficacy of presurgical evaluation methods, postoperative outcomes and characteristic pathologic features in the children who underwent epilepsy surgery. The objective of this study
is to
summarize experiences of epilepsy surgery in children with intractable partial epilepsies.

Methods: Forty-seven patients were included in this study. All had medically intractable partial epilepsy and underwent epilepsy surgery after meticulous presurgical evaluation including interictal and ictal EEG, MRI, interictal and ictal
SPECT
and FDG-PET.
Results: Out of the 47 patients, 28 had temporal lobe epilepsy, 8 frontal lobe epilepsy, 8 occipital lobe epilepsy, and 3 parietal lobe epilepsy. Pathologic findings were as follows: cortical dysplasia in 21, hippocampal
sclerosis in 8, cortical dysplasia combined with hippocampal sclerosis in 8, cortical dysplasia with tumor in 4, and cortical dysplasia, hippocampal sclerosis and tumor in 1, tumor in 4, heterotopia in 1. FDG-PET was the most sensitive imaging
modality.
MRI showed the highest specificity in terms of concordance with ictal EEG finding. Postoperative outcome was as follows: Engel class I in 34, class II in 4, class III in 3, and class IV in 6. No significant difference was found in postoperative
outcome
between the temporal and the extratemporal resection group. Postoperative seizure outcome was not correlated with MRI or pathologic finding.

Conclusion: Epilepsy surgery seems to be an effective and safe therapeutic choice in children with intractable partial epilepsies regardless of the location of epileptogenic zone. Further study is necessary on the efficacy of each imaging
modality, postoperative quality of life and the effect on long-term neurocognitive function.

Å°¿öµå

Intractable epilepsy; Epilepsy surgery;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS